News You Can Use
Updates and news related to prostate cancer:
Germline Testing
A study's implications for veteran access to prostate cancer treatments
Advances in Metastatic Castration Resistant Prostate Cancer Management
Recent approvals, emerging therapies, and future directions
FDA Receives NDA for 3-Month Version of Leuprolide Mesylate for Advanced Prostate Cancer
The trial excluded patients with recent chemotherapy, immunotherapy, or major surgeries, ensuring a focused study population.
Exercise Benefits In Prostate Cancer Active Surveillance
Older Men Increasingly Overtreated for Prostate Cancer
VA analysis finds men with limited life expectancy still getting aggressive treatment.
Survival, Progression Improves With Xofigo Plus Xtandi for Certain Patients With Prostate Cancer
Patients with metastatic, castration-resistant prostate cancer saw significant benefits from the combination of Xofigo and Xtandi.
PSMA-PET by PROMISE Criteria Shows Prognostic Value Across Prostate Cancer Continuum
PPP nomograms accurately stratify high- vs. low-risk groups for overall survival in early and late stages of prostate cancer and yield better prediction than established clinical risk tools.
A Common Culprit Drives Prostate Cancer Progression
Activation of the MYC gene in prostate cancer leads to major changes in the surrounding microenvironment.
Neoadjuvant Exercise Therapy in Prostate Cancer
Observational data have shown that postdiagnosis exercise is associated with reduced risk of prostate cancer death.
Ancient Viruses Might Be Spurring Modern-Day Cancers
Cancer growth can be fueled by flecks of ancient viral DNA lodged into the genetics of modern humans, a new study says.